Substandard and falsified medicines kill quietly, at scale. RxLoop puts guidance, reporting and adherence in the patient's hand, in five Nigerian languages, with no connection required.
Every actor in the chain, manufacturer, distributor, pharmacy, regulator, holds one fragment of the truth about a pack of medicine. None of them hold the patient's fragment. That is the gap RxLoop closes.
A falsified pack looks like medicine, costs like medicine, and is sold by someone who believes it is medicine. The failure is not one bad actor, it is that nobody downstream can check, and when something goes wrong there is no route for that signal to travel back up.
medical products in low- and middle-income countries are substandard or falsified.
WHO 2017. Verify against the blueprint before publishing.
The patient is the only person who touches every pack, and the only one with no way to check it.
RxLoop is a middleware layer between people and the medicines they already hold. It does three things: gives reference guidance a person can read in their own language, captures a report when a pack looks wrong, and keeps a full course on schedule until it is finished. All of it runs offline, because the places where falsified medicine circulates are the same places where data does not.
This is the real reference lookup from /app/, running here on the page. Pick a language, pick a medicine. General safety and adherence guidance only, never numeric dosing, which belongs to a clinician who knows the patient.
Cached by service worker, works at zero bars
A report takes fifteen seconds and no account. Today it is stored on the device that made it. The moment a moderated backend exists, the same form becomes a shared early-warning map, see live & roadmap.
You do not need lab equipment to notice that a blister is loose, the print is soft, or the tablets taste of nothing. Those observations are data, they just have nowhere to go.
Half-finished antibiotic courses are a resistance engine. Reminders fire locally while the app is installed, no server, no account, no data cost. Build a schedule and watch it land on the day.
Set the times a dose is actually convenient, after morning prayer, at lunch, before bed, not the times a leaflet assumes.
Information already flows one way: factory to patient. RxLoop builds the return path. Tap any node to see what it sends and what it gets back.
Health software that overstates itself gets people hurt. Nothing below is described as working unless you can use it today.
The patient side stays free permanently. Revenue comes from the actors who gain operational value from the return path, and none of it involves selling individual health data.
| Who | What they get | Basis | Status |
|---|---|---|---|
| Patients | Reference guidance, offline access, reporting and reminders in five languages. | Free, permanently | Live |
| Pharmacies | Batch alerts on packs their own customers flagged, plus stock and dispensing records. | Per outlet, monthly | Pilot stage |
| Manufacturers | Confirm a pack against their own serialisation data. See where imitations surface first. | Usage-based licence | Needs partner |
| Regulators | Anonymised clusters of suspect reports, ahead of formal reporting channels. | Public-interest tier | Needs backend |
The sequencing matters: the patient app has to be genuinely useful with no partners at all, or there is nothing to bring a manufacturer to the table with. That is why the offline reference layer shipped first and the computer-vision verification has not shipped at all.
Building RxLoop from Nigeria, for the pharmacies, patients and regulators who live with this problem daily rather than read about it in a market report.